Cited by 569Menopause: Health Impacts and TreatmentsVenous Thromboembolism Diagnosis and ManagementCerebral Venous Sinus Thrombosis

The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

Open access

Canonico, Marianne, Plu-Bureau, Geneviève, Lowe, Gordon D O, Scarabin, Pierre-Yves·2008·BMJ

DOI 10.1136/bmj.39555.441944.bePMC PMC2405857

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To assess the risk of venous thromboembolism in women using hormone replacement therapy by study design, characteristics of the therapy and venous thromboembolism, and clinical background. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline. STUDIES REVIEWED: Eight observational studies and nine randomised controlled trials. INCLUSION CRITERIA: Studies on hormone replacement therapy that reported venous thromboembolism. REVIEW MEASURES: Homogeneity between studies was analysed using chi(2) and I(2) statistics. Overall risk of venous thromboembolism was assessed from a fixed effects or random effects model. RESULTS: Meta-analysis of observational studies showed that oral oestrogen but not transdermal oestrogen increased the risk of venous thromboembolism. Compared with non-users of oestrogen, the odds ratio of first time venous thromboembolism in current users of oral oestrogen was 2.5 (95% confidence interval 1.9 to 3.4) and in current users of transdermal oestrogen was 1.2 (0.9 to 1.7). Past users of oral oestrogen had a similar risk of venous thromboembolism to never users. The risk of venous thromboembolism in women using oral oestrogen was higher in the first year of treatment (4.0, 2.9 to 5.7) compared with treatment for more than one year (2.1, 1.3 to 3.8; P<0.05). No noticeable difference in the risk of venous thromboembolism was observed between unopposed oral oestrogen (2.2, 1.6 to 3.0) and opposed oral oestrogen (2.6, 2.0 to 3.2). Results from nine randomised controlled trials confirmed the increased risk of venous thromboembolism among women using oral oestrogen (2.1, 1.4 to 3.1). The combination of oral oestrogen and thrombogenic mutations or obesity further enhanced the risk of venous thromboembolism, whereas transdermal oestrogen did not seem to confer additional risk in women at high risk of venous thromboembolism. CONCLUSION: Oral oestrogen increases the risk of venous thromboembolism, especially during the first year of treatment. Transdermal oestrogen may be safer with respect to thrombotic risk. More data are required to investigate differences in risk across the wide variety of hormone regimens, especially the different types of progestogens.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/bmj.39555.441944.be

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women's Health Initiative Randomized Controlled Trial
(2004) · JAMA · doi:10.1001/jama.291.14.1701 · Cited by 4,534
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1
GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644
Shape of the relapse curve and long-term abstinence among untreated smokers
Hughes, J. R., Keely, J., & Naud, S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00540.x · Cited by 1,414
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352

Show all 73 references

Research works printed but not linked: 2

Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121-45.

Sorted by citations

Items 401–500 of 567

Expert opinion by the Italian Society of Gynecology of the Third Age (SIGiTE) and the Italian Society of Menopause (SIM) on diagnosis and treatment of premature ovarian insufficiency
Capozzi, A., Ambroggio, S., Cagnacci, A., Gambacciani, M., Lello, S., & Carlo, C. D. (2025) · Minerva Endocrinology · doi:10.23736/s2724-6507.25.04422-7 · Cited by 1
Matters of the Heart: Menopause, Hormones, and Cardiovascular Disease
Guo, R., & Lau, E. S. (2025) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-025-01131-0 · Cited by 1
FDA Boxed Warning Removal on Menopause Hormone Therapy: What Geriatricians Should Know
Hanfling, S. N., Vereecken, S. J., MacRae, K., & Rubin, R. S. (2025) · Journal of the American Geriatrics Society · doi:10.1111/jgs.70256 · Cited by 1
A preliminary pilot study to address design issues related to research on potential association of hormone therapy and adhesive capsulitis
Reinke, E. K., Ford, A. C., Wahl, E. P., Kennedy, J. S., Poehlein, E., Green, C. L., Saltzman, E. B., & Wittstein, J. R. (2026) · Climacteric · doi:10.1080/13697137.2026.2615391 · Cited by 1
Thrombophilia Testing in Women and Adolescent Girls—Position Paper from the Standing Committee on Women’s Health Issues of the Society for Thrombosis and Haemostasis Research (GTH)
Linnemann, B., Bauersachs, R. M., Bergmann, F., Hart, C., Lindhoff‐Last, E., Rott, H., & Pfrepper, C. (2026) · Hämostaseologie · doi:10.1055/a-2780-3709 · Cited by 1
Estradiol treatment induces both shared and unique gene regulation and networks in adipose cell types of gonadectomized obese XX and XY mice
Zhao, Y., Liu, R., Ng, J. P., Yu, S., Ahn, I. S., Diamante, G., Zhang, G., Thorson, A. S., Schaefers, K. P., Stafford, J. M., et al. (2026) · Biology of Sex Differences · doi:10.1186/s13293-026-00859-z · Cited by 2
Terapêutica hormonal: benefícios, riscos e regimes terapêuticos
(2026) · Femina · doi:10.61622/0100-7254531202606 · Cited by 1
Menopausal Hormone Therapy and Cardiovascular Risk: Current Evidence and Clinical Implications
Buzdugă, C. M., Bobu, A. M., Covali, R. A., Costea, C. F., Cucu, A. I., Graur, M., Pătrășcanu, E., Solomon-Condriuc, I. P., & Cărăuleanu, A. (2026) · Medical Sciences · doi:10.3390/medsci14020298 · Cited by 1
Menopause Management in Patients With Cancer
Ward, K. K., Mitchem, S., & Harichand-Herdt, S. (2026) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000006393 · Cited by 1
General Perioperative Complications
Coventry, B. J., Bruening, M. H., Whitfield, R. J., & Yong, J. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5391-7_2 · Cited by 1
Medikamentöse Therapiemöglichkeiten in der Menopause
Mueck, A. O., & Seeger, H. (2011) · Gynäkologische Endokrinologie · doi:10.1007/s10304-011-0413-2 · Cited by 1
Interventions for congenital ichthyosis
Danielsen, P. L., Palanivelu, V. T., Mukhtar, S. A., Duke, J. M., & D, S. M. M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011139.pub2 · Cited by 1
Menopausal Hormone Therapy (MHT)
Anagnostis, E. A. (2012) · Journal of Pharmacy Practice · doi:10.1177/0897190012442064 · Cited by 1
Acute Pulmonary Venous Thromboembolic Disease
Sanchez, O., & Meyer, G. (2012) · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research · doi:10.1159/000334352 · Cited by 1
Terapia hormonalna okresu menopauzy a ¿y³y - czy jest siê czego baæ?
Stachowiak, G., Ginekologii, K., & Wilczyński, J. R. (2013) · Cited by 1
Pro und Contra der Thrombophiliediagnostik/Pros and cons of thrombophilia testing
Orth, M., & Schlatterer, K. (2013) · Journal of Laboratory Medicine · doi:10.1515/labmed-2012-0053 · Cited by 1
L’association estrogènes et modulateurs sélectifs du récepteur des estrogènes : un renouveau du traitement hormonal ?
Valera, M., Chantalat, É., Vinel, A., Benoit, T., Guillaume, M., Gamé, X., Gourdy, P., Trémollières, F., Payrastre, B., & Arnal, J. (2015) · La Presse Médicale · doi:10.1016/j.lpm.2015.07.003 · Cited by 1
Menopause and climacteric as a risk factor for renal and cardiovascular disease
Mihaljević, D. (2018) · Cardiologia Croatica · doi:10.15836/ccar2018.243 · Cited by 1
Endometrial Histology and Safety on Non-Oral Routes of Hormone Therapy for Perimenopausal/Early Menopausal Women: Transdermal Estrogens and Vaginal Micronized Progesterone
Russu, M. C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89046 · Cited by 1
Ménopause
Rozenbaum, H. (2010) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(10)51195-8 · Cited by 1
Menopausal symptoms.
Morris, E., & Burbos, N. (2010) · PubMed Central · Cited by 1
Exploring the potential for a set of UK hormone replacement therapy eligibility guidelines: A suggested proposal on the topic of venous thromboembolism
Laing, A., Thomas, L., Hillard, T., Panay, N., & Briggs, P. (2023) · Post Reproductive Health · doi:10.1177/20533691231223682 · Cited by 2
Pregnancy and reproductive health issues in systemic lupus erythematosus
Chakravarty, E. F., & Sammaritano, L. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93232-5.00049-6 · Cited by 1
Health correlates and mode of administration of hormones—Are there any differences between parenteral and oral estrogen preparations?
Du, Y., Schwarz, S., Knopf, H. C., & Dören, M. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.09.008 · Cited by 1
Hormone Therapy and Risk of Myocardial Infarction
Lowe, G. D. O. (2009) · Women s Health · doi:10.2217/17455057.5.1.29 · Cited by 1
Self-citation
MHT vs. veins: is there any reason to fear?
Stachowiak, G. (2013) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2013.33422 · Cited by 1
Impact of Hormone Therapy Linked to Wells Prediction Score in the Diagnosis of Deep Vein Thrombosis in Women Submitted to Vascular Ultrasound
Barros, M. V. L., Arancibia, A. E. L., Costa, A. P., Bueno, F. B., Martins, M. A. C., Magalhães, M. C., da Silva, J. L. P., & de Bastos, M. (2015) · ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR · doi:10.5935/2318-8219.20150028 · Cited by 1
ESHRE Guideline: management of women with premature ovarian
Webber, L. J., Davies, M. C., Anderson, R. A., BARTLETT, J., Braat, D. D. M., Cartwright, B., Cífková, R., Keizer‐Schrama, S. D. M., Hogervorst, E., Janse, F., et al. (2016) · Cited by 1
Primary and Preventative Care for Transgender Patients
Wolf-Gould, C., & Wolf-Gould, C. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-49642-1.00012-0 · Cited by 1
Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations.
Cattoni, A., Parissone, F., Porcari, I., Molinari, S., Masera, N., Franchi, M. P., Cesaro, S., Gaudino, R., Passoni, P., & Balduzzi, A. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.9.7 · Cited by 1
A case vignette describing management of menopausal symptoms and migraine in the perimenopause
Gilmore, K. L., & Mansour, D. (2021) · BMJ Sexual & Reproductive Health · doi:10.1136/bmjsrh-2020-200977 · Cited by 1
Klimakterium und Menopause
Noss, D., & Ortmann, O. (2012) · Springer eBooks · doi:10.1007/978-3-642-20923-9_9 · Cited by 1
Chapitre 6 : Agents thérapeutiques d'ordonnance
Author, N. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2019.02.145 · Cited by 1
Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm [editorial].
Gasparri, M. L., Taghavi, K., Fiacco, E., Zuber, V., Micco, R. D., Gazzetta, G., Valentini, A., Mueller, M. D., Papadia, A., & Gentilini, O. (2019) · doi:10.7892/boris.132358 · Cited by 1
Hormonersatztherapie - praktische Konsequenzen aus der Gesamtevidenz
Ao, M. (2009) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
A Nationwide Study on Breast Cancer Risk in Postmenopausal Women Using Hormone Therapy in Finland
Lyytinen, H. K. (2009) · Työväentutkimus Vuosikirja · Cited by 1
Prevention and Treatment of Venous and Arterial Thrombosis in Patients with Specific Conditions: Diabetes, Hypercoagulable States, Pregnancy, and Renal Insufficiency
Samama, M. M., Conard, J., & Gerotziafas, G. (2012) · Wiley eBooks · doi:10.1002/9781118410875.ch22 · Cited by 1
Postmenopausal estrogen therapy: which route to take?
Simon, J. A. (2009) · Nature Reviews Endocrinology · doi:10.1038/ncpendmet1073 · Cited by 1
Where postmenopausal hormone therapy stands today
Pines, A. (2009) · HORMONES · doi:10.14310/horm.2002.1241 · Cited by 1
Obstructive prosthetic atrioventricular valve thrombosis in a woman with congenitally corrected transposition of the great arteries during estrogen replacement therapy for pituitary dysfunction
Muneuchi, J., Yamamura, K., Shiokawa, Y., Nakashima, A., Ushijima, T., & Tominaga, R. (2010) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-009-0470-9 · Cited by 1
Menopausal Treatment
Gompel, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64947-4 · Cited by 1
Exploring the use of emergency health services for stroke: what is known about when to seek emergency help and how transport decisions impact in-hospital emergency care
Kandola, D. K. (2021) · doi:10.24124/2021/59200 · Cited by 1
Menopausale Hormontherapie zur Frakturprävention
Birkhäuser, M. (2015) · Gynäkologische Endokrinologie · doi:10.1007/s10304-015-0027-1
Pathologie Veineuse Aiguë
Luizy, F. (2011) · Elsevier eBooks · doi:10.1016/b978-2-294-71346-0.50001-x · Cited by 1
Gender Issues in Venous Thromboembolism
Murin, S., Bilello, K. L., Moores, L. K., & Holley, A. B. (2010) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-374271-1.00020-4
Pharmacokinetics of continuous once-a-week combination 17β-Estradiol/Low- or high-dose levonorgestrel transdermal delivery systems in postmenopausal women
Karara, A. H., Harrison, L. I., Melikian, A. P., Poola, N., Morrison, D., Bourg, D., Bourg, L., & Zurth, C. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.238
Thrombotic Risk Factors
Price, E. L., & Minichiello, T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9560-4_12
Microvascular reactions of normal and osteoporotic bones in response to surgical interventions
Greksa, F. (2013) · doi:10.14232/phd.1848
The Cardiovascular Spectrum of Adverse Drug Reactions
Schubert, C., & Hsia, J. A. (2014) · doi:10.1002/9781118820186.ch38
Effects of Hormones and Hormone Therapy on Cardiovascular Health in Women
Dallasen, R., Mieszczanska, H. Z., & Hartmann, D. M. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5517-1_16
ACTUALIDAD: Recomendaciones de 2013 Sobre Terapia de Remplazo Hormonal. Sociedad Británica de Menopausia y del Cuidado de la Salud de la Mujer
Goicuria, E. C., & Meza, I. B. (2012) · Revista Clínica Escuela de Medicina UCR-HSJD · doi:10.15517/rc_ucr-hsjd.v4i1.13835
Promoting confidence in HRT
Abernethy, K. (2013) · Independent Nurse · doi:10.12968/indn.2013.18.3.97555
Hormoonsubstitutietherapie en de kans op veneuze trombose: een meta-analyse
Sitsen, J. M. A. (2009) · Medisch-Farmaceutische Mededelingen · doi:10.1007/bf03079934
Menopausal Hormonal Therapy and Cardiovascular Disease
Lobo, R. A. (2014) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-014-0092-9
Vermindering in hormoonsubstitutie?
Lagro‐Janssen, A. L. M., Knufing, M. W. A., Schreurs, L., & van Weel, C. (2011) · Huisarts en Wetenschap · doi:10.1007/s12445-011-0234-5
Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study
Bouaziz-Amar, É., Canonico, M., Verstuyft, C., Carcaillon‐Bentata, L., Martin, F., Scarabin, P., & Guiochon‐Mantel, A. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.08.013
Self-citation
Current Resources for Evidence-Based Practice, January/February 2009
Jolivet, R. R. (2009) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/j.1552-6909.2008.00310.x
Postmenopausal Hormone Therapy: Does It Have a Role in Cardiovascular Prevention Today?
Honoris, L., & Budoff, M. J. (2012) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-012-0235-3
Risk-Benefit Analysis of Combination Versus Unopposed HRT in Post-Menopausal Women
Ishaq, G. M., Hussain, P. T., Iqbal, M. J., & Mushtaq, M. B. (2011) · International Journal of User-Driven Healthcare · doi:10.4018/ijudh.2011100106
Kardiovaskuläres Risiko in der Postmenopause und Hormonersatztherapie
Banz, C., Schaudig, K. T., Schwenkhagen, A., & Diedrich, K. (2008) · Der Gynäkologe · doi:10.1007/s00129-008-2209-6
Current Resources for Evidence‐Based Practice, January/February 2009
Jolivet, R. R. (2008) · Journal of Midwifery & Women s Health · doi:10.1016/j.jmwh.2008.10.014
Key-Note Lectures - Tuesday, September 14 th
Mueck, A. O. (2010)
Comparison of efficacy of the intermittent pneumatic compression with various pressures in reducing the primary lower extremity venous lymphedema of menopausal patients Porównanie skutecznoœci sekwencyjnego masa¿u uciskowego o ró¿nym ciœnieniu w leczeniu pierwotnego obrzêku ¿ylno-ch³onnego koñczyn dolnych u pacjentek w okresie menopauzalnym
Taradaj, J., Halski, T., Ozon, M., Rajfur, J. B., Chmielewska, D. D., Piecha, M., & Skrzypulec‐Plinta, V. (2013)
Routes of administration of hormone replacement therapy and cardiovascular effects in postmenopausal women
Sharma, M., Li, X., Li, L., Huang, R. X., Yang, Y. X., & Jiang, W. H. (2014) · Journal of General Practice and Emergency Medicine of Nepal · doi:10.59284/jgpeman140
Rivisitazione della terapia sostitutiva in postmenopausa alla luce dei risultati dei grandi trials
Gambacciani, M., & Marco Levancini, A. (2015) · L Endocrinologo · doi:10.1007/s40619-015-0132-3
Characterisation of oestrogen-responsive microRNAs regulating coagulation factors
Tian, J. (2015) · Murdoch University Research Portal
Avaliação de formulações contraceptivas por parâmetros hemostáticos, vasoativos e inflamatórios em cultura de células endoteliais humanas
Amaral, D. S. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.60.2015.tde-25092015-143858
Le traitement hormonal de la menopause (THM) chez les jeunes medecins generalistes de Gironde : connaissances, attitudes et pratiques
Nalet, P. (2015) · HAL
Pros and cons of thrombophilia testing1)
Orth, M., & Schlatterer, K. (2013) · Journal of Laboratory Medicine · doi:10.1515/labmed-2013-0035
Bringing the Womenʼs Health Initiative to the Patient Level in the Age of Informed Consent
Perry, J. S. (2009) · Postgraduate Obstetrics & Gynecology · doi:10.1097/01.pgo.0000347260.06059.bc
Incremental value of hormonal therapy for deep vein thrombosis prediction
Barros, M. V. L., Arancibia, A. E. L., Costa, A. P., Bueno, F. B., Martins, M. A. C., Magalhães, M. C., da Silva, J. L. P., & Pereira, M. B. (2016) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000426
New clinical data and guidelines on menopausal hormone therapy since the Women’s Health Initiative study: route of administration and safety profile
Woźniakowska, E., Milart, P., Woźniak, S., Wrona, W., Szkodziak, P. R., Paszkowski, M., Czuczwar, P., & Paszkowski, T. (2013) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2013.33427
Diagnosis and management of heritable thrombophilias
Haemophilia, O. (2014)
Current Resources for Evidence-Based Practice, January/February 2009
Proposes, M. R. (2009)
Menopause
L'Hermite, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00157-4
Quoi de neuf en médecine interne
Francès, C. (2008) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(08)75486-3
Are the benefits of low-dose estrogens really proven?
Studd, J. W. W. (2008) · Climacteric · doi:10.1080/13697130802379855
Uued seisukohad üleminekuea käsitluses
Väli, M. (2014) · Ajakirjad. Journals by UT · doi:10.15157/ea.v0i0.11679
News and views
Brown, S. (2010) · Menopause international · doi:10.1258/mi.2010.010019
Thrombotic Risk of Contraceptives and Other Hormonal Therapies
Sood, S. L., & Konkle, B. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2296-9.00033-6
Bisphosphonates-related adverse events : systematic review and meta-analysis
Medeiros, A. C. P. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Management of Estrogen Deficiency
SHUFELT, C. L., & Waldman, T. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4838-8_29
Menopausale Hormontherapie bei internistischen Erkrankungen
Birkhäuser, M. (2016) · Gynäkologische Endokrinologie · doi:10.1007/s10304-016-0090-2
Menopausale Hormontherapie bei internistischen Erkrankungen
Birkhäuser, M. (2016) · gynäkologie + geburtshilfe · doi:10.1007/s15013-016-1035-5
Obstetrics, Contraception, and Estrogen Replacement
Webster, A., & Pavord, S. R. (2016) · Wiley eBooks · doi:10.1002/9781118344729.ch26
Venous Thromboembolism
Fitzgerald, K. C., & Glynn, R. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384978-6.00067-4
Menopausale Hormontherapie — ein Update
Blickenstorfer, K., & Leeners, B. (2017) · gynäkologie + geburtshilfe · doi:10.1007/s15013-017-1050-1
Menopausale Hormontherapie (MHT) bei internistischen Erkrankungen
Birkhäuser, M. (2014) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Menstrual Disorders in Post-menarcheal Girls
Pampaloni, F., & Mertino, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-57162-1_7
Hormone Therapy and Risk for Venous Thromboembolism
Mueller, P. S., & FACP., F. (2008) · Journal watch · doi:10.1056/jw200807010000003
Systemic Non-Reproductive Effects of Sex Steroids in Adult Males and Females
Shah, S. I. A. (2018) · Human Physiology · doi:10.1134/s0362119718010188 · Cited by 1
Management of Menopausal Symptoms in the Post-Women’s Health Initiative Era
Stuenkel, C. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384978-6.00059-5
WITHDRAWN: Women, thrombosis, and cancer
Farge, D., Maignan, C. L., Doucet, L. S., & Frère, C. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.02.019
Epidemiology of venous thromboembolism with focus on risk markers
Johansson, M. (2019) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Patología iatrogénica en medicina vascular
Lapébie, F.-X., Mirault, T., Bura-Rivière, A., & Emmerich, J. (2019) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(19)41992-2
Sex Differences, Progesterone, and Ischemic Stroke
Schumacher, M., & Guennoun, R. (2019) · ISGE series · doi:10.1007/978-3-030-11355-1_14
Care of Transgender Individuals
Pratt, A., & Jackson, M. B. (2019) · Springer eBooks · doi:10.1007/978-3-030-19704-9_45
Pathologie veineuse thrombo-embolique
Plu‐Bureau, G., & Raccah-Tebeka, B. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-74372-6.00024-2
Self-citation
Hormone replacement therapy: update and practical prescribing
Noble, N. (2021) · Practice Nursing · doi:10.12968/pnur.2021.32.4.148
Efficacy and effects of transdermal hormone therapy in postmenopausal women
Correia, L. E. P., de Almeida, B. C., Baracat, E. C., Silva, I., Júnior, J. M. S. J., Bonduki, C. E., & Haidar, M. A. (2018) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog4328.2018

Authors: Canonico, M., Plu-Bureau, G., Lowe, G. D. O., & Scarabin, P.-Y.
Affiliations: Université Paris-Sud (FR)
Glasgow Royal Infirmary (GB)
Corresponding author: Canonico, Marianne
ORCID: Canonico, Marianne
Lowe, Gordon D O
Scarabin, Pierre-Yves
Venue: BMJ
Publisher: BMJ
Published: 2008-05-20
Volume: 336
Issue: 7655
Pages: 1227-1231
ISSN: 0007-1447 (ISSN-L)
0959-8138
1468-5833
DOI: 10.1136/bmj.39555.441944.be
PMC: PMC2405857
OpenAlex: W2008660261
Cited by: 569
References: 73
Citations by year: 2026: 25 · 2025: 31 · 2024: 20 · 2023: 17 · 2022: 29 · 2021: 30 · 2020: 21 · 2019: 29 · 2018: 27 · 2017: 26 · 2016: 30 · 2015: 28 · 2014: 32 · 2013: 45 · 2012: 35
FWCI: 6.50
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.bmj.org/licenses/tdm/1.0/terms-and-conditions.html (tdm)
Locations: BMJ (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion, other-oa)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Clinical Neurology › Cerebral Venous Sinus Thrombosis
Keywords: hormone replacement therapy, venous thromboembolism, postmenopausal women, oral estrogen, transdermal estrogen, obesity, unopposed estrogen, progestogens, thrombosis risk, treatment duration
MeSH terms: Administration, Cutaneous, Administration, Oral, Female, Humans, Risk, Risk Factors, Estrogen Replacement Therapy, Randomized Controlled Trials as Topic, Postmenopause, Venous Thromboembolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks